Saeki C, Saito M, Tsubota A
J Bone Miner Metab. 2024; 42(4):399-412.
PMID: 38302761
DOI: 10.1007/s00774-023-01488-x.
De A, Ray D, Lamoria S, Sharma V, Khurana T
JGH Open. 2020; 4(5):945-949.
PMID: 33102768
PMC: 7578334.
DOI: 10.1002/jgh3.12369.
Jeong H, Kim D
Int J Mol Sci. 2019; 20(17).
PMID: 31480433
PMC: 6747370.
DOI: 10.3390/ijms20174270.
Ehnert S, Aspera-Werz R, Ruoss M, Dooley S, Hengstler J, Nadalin S
Int J Mol Sci. 2019; 20(10).
PMID: 31137669
PMC: 6566554.
DOI: 10.3390/ijms20102555.
Megahed A, Salem N, Fathy A, Barakat T, Alsayed M, Mabood S
World J Pediatr. 2017; 13(4):346-352.
PMID: 28130750
DOI: 10.1007/s12519-017-0013-x.
Diagnosis and Management of Cirrhosis-Related Osteoporosis.
Santos L, Romeiro F
Biomed Res Int. 2016; 2016:1423462.
PMID: 27840821
PMC: 5093239.
DOI: 10.1155/2016/1423462.
Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.
Karoli Y, Karoli R, Fatima J, Manhar M
J Clin Diagn Res. 2016; 10(8):OC31-4.
PMID: 27656483
PMC: 5028496.
DOI: 10.7860/JCDR/2016/21539.8367.
Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.
Lan G, Xie X, Peng L, Liu L, Song L, Dai H
Biomed Res Int. 2015; 2015:413169.
PMID: 26649301
PMC: 4662986.
DOI: 10.1155/2015/413169.
Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.
Lopez-Larramona G, Lucendo A, Gonzalez-Castillo S, Tenias J
World J Hepatol. 2012; 3(12):300-7.
PMID: 22216370
PMC: 3246548.
DOI: 10.4254/wjh.v3.i12.300.
Hepatobiliary complications of inflammatory bowel disease.
Lichtenstein D
Curr Gastroenterol Rep. 2011; 13(5):495-505.
PMID: 21773706
DOI: 10.1007/s11894-011-0213-9.
Bone mineral density and disorders of mineral metabolism in chronic liver disease.
George J, Ganesh H, Acharya S, Bandgar T, Shivane V, Karvat A
World J Gastroenterol. 2009; 15(28):3516-22.
PMID: 19630107
PMC: 2715978.
DOI: 10.3748/wjg.15.3516.
Cholestasis and metabolic bone disease - a clinical review.
Gasser R
Wien Med Wochenschr. 2008; 158(19-20):553-7.
PMID: 18998071
DOI: 10.1007/s10354-008-0594-z.
Is osteoporosis a peculiar association with primary biliary cirrhosis?.
Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P
World J Gastroenterol. 2005; 11(34):5347-50.
PMID: 16149144
PMC: 4622807.
DOI: 10.3748/wjg.v11.i34.5347.
Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.
Schiefke I, Fach A, Wiedmann M, Aretin A, Schenker E, Borte G
World J Gastroenterol. 2005; 11(12):1843-7.
PMID: 15793878
PMC: 4305888.
DOI: 10.3748/wjg.v11.i12.1843.
Treatment of Biliary Problems in Inflammatory Bowel Disease.
Huang C, Lichtenstein D
Curr Treat Options Gastroenterol. 2005; 8(2):117-126.
PMID: 15769433
DOI: 10.1007/s11938-005-0004-1.
